{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:41:21Z","timestamp":1784122881681,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1124\/jpet.110.176271","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T02:57:56Z","timestamp":1294887476000},"page":"218-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["In Vivo Effects of Amphetamine Analogs Reveal Evidence for Serotonergic Inhibition of Mesolimbic Dopamine Transmission in the Rat"],"prefix":"10.1016","volume":"337","author":[{"given":"Michael H.","family":"Baumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Woolverton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunmee","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Blough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.176271_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.110.176271_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0893-133X(01)00345-1","article-title":"Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B\/1D) and 5-HT(2) receptors","volume":"26","author":"Bankson","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.110.176271_bib3","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1471-4159.2004.02763.x","article-title":"Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release","volume":"91","author":"Bankson","year":"2004","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.110.176271_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pbb.2008.02.018","article-title":"Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain","volume":"90","author":"Baumann","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.110.176271_bib5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0006-3223(98)00123-1","article-title":"Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans","volume":"44","author":"Baumann","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.110.176271_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2010.09.015","article-title":"Serotonin (5-HT) precursor loading with 5-hydroxy-L-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat","author":"Baumann","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.110.176271_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse","volume":"172","author":"Bubar","year":"2008","journal-title":"Progr Brain Res"},{"key":"10.1124\/jpet.110.176271_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1471-4159.2007.05195.x","article-title":"Substrates dissociate dopamine transporter oligomers","volume":"105","author":"Chen","year":"2008","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.110.176271_bib9","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.bjp.0701325","article-title":"Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine","volume":"121","author":"Crespi","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.110.176271_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0079-6123(08)00903-5","article-title":"Serotonin-dopamine interaction: electrophysiological evidence","volume":"172","author":"Di Giovanni","year":"2008","journal-title":"Progr Brain Res"},{"key":"10.1124\/jpet.110.176271_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0079-6123(08)00902-3","article-title":"Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies","volume":"172","author":"Di Matteo","year":"2008","journal-title":"Progr Brain Res"},{"key":"10.1124\/jpet.110.176271_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.110.176271_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00213-006-0453-9","article-title":"The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists","volume":"187","author":"Fletcher","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.110.176271_bib14","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5386-08.2009","article-title":"Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopy","volume":"29","author":"Furman","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.110.176271_bib15","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.addbeh.2004.06.018","article-title":"Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence","volume":"29","author":"Grabowski","year":"2004","journal-title":"Addict Behav"},{"key":"10.1124\/jpet.110.176271_bib16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1046\/j.1471-4159.1999.0731066.x","article-title":"The \u03ba-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum","volume":"73","author":"Gray","year":"1999","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.110.176271_bib17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0022-3565(25)25056-X","article-title":"Comparison of amphetamine metabolism using isolated hepatocytes from five species including human","volume":"237","author":"Green","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.176271_bib18","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/oby.2009.69","article-title":"How physician obesity specialists use drugs to treat obesity","volume":"17","author":"Hendricks","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/jpet.110.176271_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1749-6632.2009.05145.x","article-title":"Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies","volume":"1187","author":"Herin","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.110.176271_bib20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1124\/jpet.106.108324","article-title":"Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys","volume":"320","author":"Howell","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.176271_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0165-0173(99)00023-5","article-title":"The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking","volume":"31","author":"Ikemoto","year":"1999","journal-title":"Brain Res Rev"},{"key":"10.1124\/jpet.110.176271_bib22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.pbb.2009.09.007","article-title":"Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey","volume":"94","author":"Kimmel","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.110.176271_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0090-9556(24)15372-X","article-title":"Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat","volume":"28","author":"Law","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.176271_bib24","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1471-4159.2009.06034.x","article-title":"Interaction of catechol and non-catechol substrates with externally or internally facing dopamine transporters","volume":"109","author":"Liang","year":"2009","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.110.176271_bib25","first-page":"305","article-title":"Effect of l-tryptophan pretreatment on d-amphetamine self administration","volume":"4","author":"Lyness","year":"1983","journal-title":"Substance Alcohol Actions\/Misuse"},{"key":"10.1124\/jpet.110.176271_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(95)00478-5","article-title":"Psychostimulant-like effects of p-fluoroamphetamine in the rat","volume":"287","author":"Marona-Lewicka","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.110.176271_bib27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","article-title":"Analysis of serial measurements in medical research","volume":"300","author":"Matthews","year":"1990","journal-title":"BMJ"},{"key":"10.1124\/jpet.110.176271_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","article-title":"Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial","volume":"101","author":"Mooney","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.110.176271_bib29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.106.107383","article-title":"Monoamine releasers with varying selectivity for dopamine\/norepinephrine versus serotonin release as candidate \u201cagonist\u201d medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys","volume":"320","author":"Negus","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.176271_bib30","series-title":"Comprehensive Medicinal Chemistry II","first-page":"169","article-title":"Addiction","author":"Newman","year":"2007"},{"key":"10.1124\/jpet.110.176271_bib31","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1982"},{"key":"10.1124\/jpet.110.176271_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.brainresrev.2008.02.004","article-title":"Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway","volume":"58","author":"Rice","year":"2008","journal-title":"Brain Res Rev"},{"key":"10.1124\/jpet.110.176271_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s002130051022","article-title":"Self-administration of cocaine analogs by rats","volume":"144","author":"Roberts","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.110.176271_bib34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/MJT.0b013e31818e30da","article-title":"Treatment of obesity with \u201ccombination\u201d pharmacotherapy","volume":"17","author":"Rothman","year":"2010","journal-title":"Am J Ther"},{"key":"10.1124\/jpet.110.176271_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","article-title":"Monoamine transporters and psychostimulant drugs","volume":"479","author":"Rothman","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.110.176271_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1196\/annals.1369.064","article-title":"Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs","volume":"1074","author":"Rothman","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1124\/jpet.110.176271_bib37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tips.2006.10.006","article-title":"Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction","volume":"27","author":"Rothman","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.110.176271_bib38","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1124\/jpet.104.082503","article-title":"Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration","volume":"313","author":"Rothman","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.176271_bib39","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/oby.2008.537","article-title":"Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women","volume":"17","author":"Smith","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/jpet.110.176271_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0091-3057(86)90261-3","article-title":"The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings","volume":"25","author":"Swerdlow","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.110.176271_bib41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1476-5381.2009.00624.x","article-title":"Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment","volume":"160","author":"Vizi","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.110.176271_bib42","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1124\/jpet.104.080101","article-title":"Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs","volume":"313","author":"Wee","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.176271_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pbb.2006.05.022","article-title":"Self-administration of mixtures of fenfluramine and amphetamine by rhesus monkeys","volume":"84","author":"Wee","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.110.176271_bib44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drugalcdep.2008.10.005","article-title":"Changes in feeding and locomotion induced by amphetamine analogs in rats","volume":"100","author":"Wellman","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.110.176271_bib45","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1471-4159.1989.tb02514.x","article-title":"Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis","volume":"52","author":"Westerink","year":"1989","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.110.176271_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03033808","article-title":"Dopamine and reward: the anhedonia hypothesis 30 years on","volume":"14","author":"Wise","year":"2008","journal-title":"Neurotox Res"},{"key":"10.1124\/jpet.110.176271_bib47","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.108.146142","article-title":"Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil","volume":"329","author":"Zolkowska","year":"2009","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524463192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524463192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.176271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:28:00Z","timestamp":1740018480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524463192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0022356524463192"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.176271","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vivo Effects of Amphetamine Analogs Reveal Evidence for Serotonergic Inhibition of Mesolimbic Dopamine Transmission in the Rat","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.176271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}